51KA.F - AVITA Medical, Inc.

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in EUR

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 6/8/2023
Current
3/31/202312/31/20229/30/20226/30/20223/31/2022
Market Cap (intraday)
335.06M324.48M154.99M134.21M113.69M189.61M
Enterprise Value
268.24M252.56M77.07M48.93M34.58M114.13M
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
9.189.584.904.083.586.36
Price/Book (mrq)
4.483.941.861.461.212.01
Enterprise Value/Revenue
7.1723.948.155.384.1515.14
Enterprise Value/EBITDA
-10.40-27.90-14.84-8.99-5.65-12.07

Yahoo Finance Plus Essential access required.

Learn more

Trading Information

Stock Price History

Beta (5Y Monthly) 0.97
52-Week Change 3137.04%
S&P500 52-Week Change 36.21%
52 Week High 314.80
52 Week Low 34.30
50-Day Moving Average 312.58
200-Day Moving Average 38.47

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 525.33M
Implied Shares Outstanding 6N/A
Float 8113.69M
% Held by Insiders 11.27%
% Held by Institutions 118.05%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:5
Last Split Date 3Jun 30, 2020

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Mar 31, 2023

Profitability

Profit Margin -70.59%
Operating Margin (ttm)-74.61%

Management Effectiveness

Return on Assets (ttm)-17.53%
Return on Equity (ttm)-30.13%

Income Statement

Revenue (ttm)37.43M
Revenue Per Share (ttm)0.30
Quarterly Revenue Growth (yoy)39.90%
Gross Profit (ttm)28.38M
EBITDA -27.39M
Net Income Avi to Common (ttm)-26.42M
Diluted EPS (ttm)-1.12
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)73.45M
Total Cash Per Share (mrq)0.58
Total Debt (mrq)1.87M
Total Debt/Equity (mrq)2.41
Current Ratio (mrq)7.20
Book Value Per Share (mrq)0.61

Cash Flow Statement

Operating Cash Flow (ttm)-18.79M
Levered Free Cash Flow (ttm)-7.54M